The Marlborough, MA-based company has signed an agreement to acquire Cortex, a developer of a diagnostic mapping solution, that may identify triggers and drivers outside of the pulmonary veins that are foundational to atrial fibrillation.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,